A-1.6. Testimony

HHSC allows members of the public to submit two types of testimony to the DUR board:

  • Written testimony: submitted electronically or on paper in the weeks before the meeting
  • Public testimony: oral presentations on the day of the meeting

Your testimony must address one of the agenda items related to the preferred drug list, prospective or retrospective drug utilization reviews, or retrospective drug use criteria. You must complete one form for each type of presentation. Any special testimony instructions are announced before the meeting.

Individuals providing testimony must complete the appropriate testimony form and the Public Comment Registration form linked on the agenda.